EAM Investors’s TRIUS THERAPEUTICS INC COM STK (DE) TSRX Stock Holding History

EAM Investors’s Portfolio TSRX Stock Details TSRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-270,881	Closed	-$2.2M	–	424
2013 Q2	$2.2M	Buy	+270,881	New	+$2M	0.48%	47

Other funds holding TSRX

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Freestone Capital Holdings Seattle, Washington $3.3B AUM 21.14% 1-Year Est. Return

Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

EAM Investors's TSRX Position: Q3 2013 in Review

EAM Investors sold out of TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) in Q3 2013, closing a stake of 270,881 shares — an estimated $2.2M sold.

EAM Investors first reported a position in TSRX in Q2 2013 and held it in 1 quarter. The position peaked at $2.2M in Q2 2013. 7 funds tracked by Wall St. Rank hold TSRX as of Q3 2013.

EAM Investors reported no remaining TRIUS THERAPEUTICS INC COM STK (DE) position as of Q3 2013 after selling out during the quarter.
EAM Investors sold 270,881 TRIUS THERAPEUTICS INC COM STK (DE) shares in Q3 2013, an estimated $2.2M.
EAM Investors first reported a position in TRIUS THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 1 quarter.
EAM Investors's TRIUS THERAPEUTICS INC COM STK (DE) position peaked at $2.2M in Q2 2013.
7 funds tracked by Wall St. Rank held TRIUS THERAPEUTICS INC COM STK (DE) as of Q3 2013.

Based on EAM Investors's 13F filing for Q3 2013, filed 13 Nov 2013.